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ABSTRACT
Introduction Very little is known about the influence 
of socioeconomic status on type 1 diabetes mellitus 
(T1DM) complications. Our aim was to determine whether 
socioeconomic level is a risk factor for the development of 
diabetic retinopathy (DR) in patients with T1DM.
Research design and methods A cohort of 150 
patients with T1DM were studied prospectively over 
9 years. Socioeconomic status was assessed using 
a neighborhood- level measure based on an index of 
deprivation. The contribution of other variables such as 
hypertension, dyslipidemia, diabetic nephropathy and 
smoking habit was evaluated. Cox proportional hazards 
models were used to quantify the associations.
Results The incidence of DR was 21.6 cases per 1000 
patient- years. Multivariable analyses showed that for each 
percentage point increase in glycated hemoglobin (HbA1c), 
the risk of developing DR increased by 58% (HR 1.58, 95% 
CI 1.19 to 2.10).
Patients with T1DM onset >18 years of age and resident 
in areas of lower socioeconomic levels presented with 
almost triple the risk of developing DR (HR 2.95, 95% CI 
1.08 to 8.00) compared with those with onset <18 years 
of age and resident in less deprived areas. We did not find 
significant relationships with other variables studied such 
as hypertension, dyslipidemia, diabetic nephropathy and 
smoking habit.
Conclusions Low socioeconomic level is a risk factor, 
independent of glycemic control, in the development of 
DR in patients with T1DM when the onset of diabetes is in 
adulthood. This finding indicates that socioeconomic status 
and age of onset need to be considered in population 
screening for DR in patients with T1DM.
INTRODUCTION
Diabetes mellitus (DM) comprises several 
clinical entities with different etiologies, but 
which has hyperglycemia as its principal char-
acteristic.1 The worldwide prevalence of DM 
in 2017 was estimated at around 425 million 
persons, and this level is expected to rise by 
48% by 2045 to reach a level of 629 million.2 
Of the total number of patients with DM, 
approximately 5%–10% suffer type 1 diabetes 
mellitus (T1DM) (1 in every 300–500 people 
<18 years of age).
Diabetic retinopathy (DR) is the principal 
cause of acquired blindness in developed 
countries, and represents 5% of all causes 
of acquired blindness worldwide. One in 
every three patients with DM have some 
grade of DR, and is three times more preva-
lent in patients with T1DM than with type 2 
diabetes mellitus (T2DM).3 The duration of 
the disease and metabolic (glycemic) control 
have been traditionally considered the prin-
cipal risk factors associated with the appear-
ance and progression of DR in patients with 
DM. Other factors such as hypertension, 
dyslipidemia, diabetic nephropathy, and the 
smoking habit have been described as having 
some involvement as well.3–6
Socioeconomic factors influencing the 
development and progression of some clinical 
processes have been well documented, such as 
in cardiovascular diseases.7 8 In DM, data indi-
cate that a low socioeconomic level is associated 
Significance of this study
What is already known about this subject?
 ► Although socioeconomic status is related to import-
ant chronic diseases in general and type 2 diabetes 
mellitus in particular, very little is known about its 
influence on complications in patients with type 1 
diabetes mellitus.
What are the new findings?
 ► In our study we observed a clear association be-
tween the level of socioeconomic deprivation and 
the incidence of diabetic retinopathy, independent of 
the level of the patient’s glycemic control.
How might these results change the focus of 
research or clinical practice?
 ► It is essential to develop and promote new social 
policies centered in patients with type 1 diabetes 
mellitus with the objective of reducing the conse-
quences of social inequalities in groups with low 
socioeconomic levels.
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with a poorer clinical evolution of the complications specific 
to DM, such as higher morbidity and mortality,9 10 even in 
countries with universal healthcare systems.
A low socioeconomic status has been associated with 
delayed diagnosis and poorer outcomes in cases of 
amblyopia,11 macular edema12 and glaucoma.13 14 Low 
economic status has also been associated with higher DR 
prevalence and more advanced forms of the disease. This 
has been attributed to lower participation in screening 
programs,15–17 as well as lower likelihood of being 
routinely followed up.
The principal objective of our study was to analyze the 
relationship between socioeconomic level and the devel-
opment of DR in a cohort of patients with T1DM, without 
DR at the start of the follow- up. Other influencing factors 
taken into account were the level of metabolic control, 
hypertension, dyslipidemia, diabetic nephropathy, and 
the smoking habit.
This project was implemented in southern Spain 
(Andalusia) within the context of a universal public 
health service. The comprehensive program (‘Integrated 
Plan for Diabetes in Andalusia’) includes early detection 
of DR using digital retinography.18 19
RESEARCH DESIGN AND METHODS
Study ambit
The study was developed within the catchment area of the 
Hospital Universitario Puerta del Mar de Cádiz (Andalusia, 
Spain) which provides healthcare for 247 000 citizens, of 
whom approximately 1500 are patients with T1DM.
Study design
The prospective cohort of patients with T1DM belonged 
to the Early Diabetic Retinopathy Detection Plan (Plan 
de Detección Precoz de la Retinopatía Diabética) of Andalusia 
conducted using digital imaging or retinography, and 
with a maximum period of follow- up of 9 years.
Study subjects
A total of 150 patients with T1DM, without DR at the start 
of the follow- up, were recruited into the study. Of these, 
78 had early- onset (0–18 years of age) T1DM, and 72 at a 
later age (>18 years).20 The duration of the follow- up of 
the cohort was for 9 years, between 2008 and 2017.
DM diagnosis was performed according to American 
Diabetes Association guideline.21 When the patients had 
equivocal signs and symptoms of T1DM (such as ketoaci-
dosis) at the start of the study, diagnosis was confirmed by 
the presence of autoantibodies (antiglutamic decarboxylase 
and anti- IA2) and decrease in fasting C- peptide (<0.5 ng/
dL) and fasting plasma glucose >250 mg/dL or following 
intravenous glucagon- stimulated C- peptide test.22
Inclusion criteria
Patients with T1DM >14 years of age, without DR at the 
start of the follow- up and who are within the catchment 
area of the Puerta del Mar University Hospital (Cádiz).
Exclusion criteria
Retinography with signs of other ocular disease, or non- 
evaluable retinography, or type of DM other than T1DM.
Variables recorded in the study
Dependent variables
Grade of DR: Defined and classified according to the 
International Clinical Diabetic Retinopathy Disease 
Severity Scale. In case of different grades of severity in 
the two eyes, we accepted the eye with the greater severity 
as reference.
Duration of the T1DM: Numbers of years between the 
age of onset of the T1DM and the age when the retinog-
raphy first showed signs of DR. For patients not devel-
oping DR, the duration was considered up to the last 
retinography performed in the follow- up.
Independent variables
Age at onset of T1DM: Data collected from the electroni-
cally stored patient history.
Grade of metabolic control: Determined as the level 
of glycated hemoglobin (HbA1c) (mmol/L and %). For 
the statistical analyses we used the baseline HbA1c and 
mean HbA1c obtained from the annual determinations 
recorded during the follow- up.
Arterial hypertension: Dichotomous variable. The 
patient was considered to be hypertensive if this was 
recorded (>140/90 mm Hg) at DM diagnosis, or patients 
receiving any antihypertension medication.
Dyslipidemia: Dichotomous variable. Defined as the 
presence of high low- density lipoprotein cholesterol 
(LDL cholesterol >100 mg/dL) and/or hypertriglyceri-
demia (triglycerides >200 mg/dL)23 or patients being in 
receipt of hypolipidemic medication, recorded at DM 
diagnosis.
Diabetic nephropathy: Dichotomous variable. Defined 
as the presence of renal damage by direct method 
(renal biopsy), albumin excretion ≥30 mg/g creatinine 
(urinary albumin/creatinine ratio) or ≥30 mg/24 hours 
confirmed in at least two or three samples in the previous 
6 months, or glomerular filtration of <60 mL/min/1.73 
m2, calculated with the Cockcroft- Gault equation for 
conventional (24- hour urine) creatinine clearance, or 
isotopic methods.
Smoking habit: Dichotomous variable. Defined by 
current consumption, or consumption in the year prior 
to the start of the follow- up period.
Socioeconomic status: To measure the socioeconomic 
status of the cases, an artificial index of deprivation of 
the census tract of residence was used. The index has 
been applied previously in epidemiological research on 
inequalities in mortality and morbidity in Andalusia.24 25
The index is calculated for each census tract using three 
census variables: (1) the percentage of persons (both 
genders) with low levels of education (unable to read 
or write, or <5 years of conventional schooling) in the 
general population ≥16 years of age; (2) the percentage 
of unemployed people (unemployed population ≥16 
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years divided by the actively employed population ≥16 
years); and (3) the percentage of unskilled workers 
(unskilled population ≥16 years divided by the employed 
population ≥16 years). A principal component analysis 
was carried out with the standardized values of the three 
variables to calculate the index. The necessary condi-
tions for its application were verified by the Bartlett sphe-
ricity test and the Kaiser- Meyer- Olkin sampling adequacy 
measure. The census tracts were ranked and categorized 
into five groups according to quintiles. Level 1 represents 
the areas with the least deprivation and level 5 represents 
the sectors with the highest levels of deprivation in the 
population.
Follow-up
Annually, from the date of inclusion in the study, three 
images of each eye were made with a non- mydriatic 
digital retinography (Topcon NW-200). One of the 
images centered in the macula (central), another in the 
optic disc (nasal) and another temporal to the macula 
(temporal). All images were reviewed independently by 
two DR expert ophthalmologists (authors SJC, PAM).
The first retinography free of DR was considered as the 
basal level. The detection of any grade of DR requiring 
ophthalmological treatment, or other alterations that 
required specialist evaluation, signaled the transfer of the 
patient out of the follow- up study.
Statistical analyses
The baseline characteristics of the patients included in the 
study were established and the cumulative incidence and 
the incidence rate of DR were calculated. Person- years 
of follow- up were estimated for each case by computing 
the time between the date of onset and the date of last 
follow- up, with respect to the development of DR or the 
completion of the study. The risk factors associated with 
the development of DR were compared. Initially, the 
distributions of these factors between those patients who 
did develop DR were compared with those who did not 
develop DR using χ2 test for categorical variables and 
the Mann- Whitney U test for quantitative variables. The 
incidence rates of subgroups of each of the risk factors 
were calculated, as were the incidence rate ratios with 
their 95% CIs. Finally, once the most important covari-
ables were identified, regression models were developed 
using Cox proportional hazards models to calculate the 
adjusted HR of each of the variables, using years from 
diagnosis of T1DM up to the event as the time variable. In 
the final step, interaction between the included variables 




The baseline characteristics of the patients are presented 
in table 1. Of the total patients in the screening program, 
150 (78/150 women) without DR were incorporated in 
the follow- up program. The mean age at the start of the 
study was 31.6±11.6 years, with a mean age at onset of 
T1DM of 19.9±11.3 years, and a mean duration of DM 
of 17±8.9 years of clinical evolution of DM at the start 
of the follow- up period. The mean HbA1c was 7.7% (60 
mmol/mol), and 68.7% of the patients had HbA1c >7% 
(53 mmol/mol). Hypertension was present in 15.3%, 
dyslipidemia in 16.7%, diabetic nephropathy in 6.7% 
and smoking habit in 24.7%. Nearly 16% of the patients 
(n=23) were resident in socioeconomic- deprived (grades 
4 and 5) census tracts (table 1).
Cumulative incidence and incidence rate of DR
At the end of the follow- up period, of the 150 patients 
studied (2250 patient- years), 55 had presented with 
DR, implying a cumulative incidence of 36.6% and an 
incidence rate of 21.6/1000 patient- years. Of these 55 
patients with DR, 30 were slight and 25 were of moderate 
DR, implying an incidence of 20.0% and 16.6%, respec-
tively. We did not observe any severe case of DR at the 
end of the follow- up period.
Risk factors associated with DR development
Table 2 summarizes the principal characteristics studied 
in patients who developed DR, as well as those who did 
not develop DR over the long- term follow- up. In the bivar-
iate analysis, we observed that the patients with DR were 
younger at the onset of T1DM (15.7±11.5 vs 22.3±10.5 
Table 1 Baseline characteristics of the patients at the start 








Age (years) 31.9±11.8 31±11.2
Sex (%) (males:females) 47.4/52.6 49.1/50.9
Age at onset (years) 22.3±10.5 15.7±11.5
Duration of T1DM (years) 9.7±7.2 15.4±9.5
HbA1c (%) 7.6±1.3 7.8±1.1
HbA1c >7% (%) 63.2 78.2
Hypertension (%) 15.8 14.5
Dyslipidemia (%) 13.7 21.8
Diabetic nephropathy (%) 6.3 7.3
Smoking habit (%) 25.3 23.6
Deprivation index (level 1), 
n (%)
42 (44.2) 17 (30.9)
Deprivation index (level 2), 
n (%)
34 (27.8) 19 (34.5)
Deprivation index (level 3), 
n (%)
6 (6.3) 9 (16.4)
Deprivation index (level 4), 
n (%)
11 (11.6) 6 (10.9)
Deprivation index (level 5), 
n (%)
2 (2.1) 4 (7.3)
DR, diabetic retinopathy; HbA1c, glycated hemoglobin; T1DM, 
type 1 diabetes mellitus.
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years; p<0.050), had a longer duration of the disease 
(15.4±9.5 vs 9.7±7.2 years; p<0.050), higher values of 
basal HbA1c (7.8%±1.1% (62 mmol/mol) vs 7.6%±1.3% 
(59 mmol/mol); p<0.05) and mean HbA1c (7.8%±1.1% 
(62 mmol/mol) vs 7.6%±1.1% (60 mmol/mol); p=0.060) 
over the period of follow- up.
Table 3 summarizes the incidence rate for each socio-
economic category, and the incidence rate ratio of DR of 
the different variables studied. The patients with HbA1c 
>7% had an incidence rate of 24.0 cases/1000 patient- 
years, while the rate was 14.7 cases/1000 patient- years 
in those with HbA1c <7% (p=0.078). With respect to 
the socioeconomic variable, the DR incidence rate in 
those with levels 4 and 5 (higher deprivation) compared 
with those with levels 1–3 (less deprivation) was 25.7 
cases/1000 patient- years vs 21.4 cases/1000 patient- years; 
p=0.291.
The results obtained with the Cox proportional hazards 
regression (table 4) showed that, in the final model, the 
variables that explained the most risk of developing DR 
were: HbA1c, age of onset of DM, and level of deprivation 
associated with the residence census tract. The propor-
tional hazards model indicates that these three variables 
have independent influences on the log hazard function 
describing the risk of DR.
Following adjustment for covariates in the model, 
HbA1c was significantly associated with developing DR 
(hazard rate: 1.6; 95% CI 1.19 to 2.10), that is, for every 
point increase in the mean value of HbA1c there is an 
increase of 60% in risk of DR. Also, the adjusted model 
identified a significant interaction between the level of 
deprivation and the age of onset of DM. Compared with 
the reference level (onset of DM <18 years of age and 
resident in less socioeconomically deprived area), the 
group with later onset (>18 years of age) and resident 
in the area of highest socioeconomic deprivation had 
triple the risk of developing DR (HR 2.95; 95% CI 1.08 
to 8.00). No significant associations of the appearance of 
DR were observed with the rest of the combinations of 
age of onset and socioeconomic status.
Additionally, to rule out a potential role of HbA1c in 
mediating the effect of socioeconomic status on the devel-
opment of DR, we calculated the mean and SD of HbA1c 
in each of the six subgroups; very similar results were 
observed (onset <18 years and less deprived=7.94±1.16; 
onset <18 years and medium deprivation=7.74±0.98; 
onset <18 years and deprived=7.98±1.47; onset >18 
years and less deprived=7.40±0.61; onset >18 years and 
medium deprivation=7.63±1.42; onset >18 years and 
deprived=7.85±1.10).
DISCUSSION AND CONCLUSIONS
In our study we observed a clear association between the 
level of socioeconomic deprivation and the incidence of 
DR, independent of the level of the patient’s glycemic 
control. This relationship is evident when the results are 









Age (years) 31.9±11.8 31±11.2 0.590
Males (%) 47.4 49.1 0.830
Age of DM onset 
(years)
22.3±10.5 15.7±11.5 0.001
Age of onset >18 
years (%)
61 38.1 0.007
Duration of T1DM 
(years)
9.7±7.2 15.4±9.5 0.001
HbA1c baseline (%) 7.6±1.3 7.8±1.1 0.040
HbA1c mean (%) 7.6±1.1 7.8±1.1 0.060
HbA1c >7% (%) 63.2 78.2 0.050
Hypertension (%) 15.8 14.5 0.830




Smoking habit (%) 25.3 23.6 0.820
DM, diabetes mellitus; DR, diabetic retinopathy; HbA1c, glycated 
hemoglobin; T1DM, diabetes mellitus.







rate ratio 95% CI P value
Sex (male/female) 28:1370/27:1180 20.4/22.8 0.9 0.51 to 1.57 0.338
Deprivation; census section (4–5/1–3) 10:389/45:2107 25.7/21.4 1.2 0.5 to 2.4 0.291
HbA1c (>7%/<7%) 45:1873/10:677 24/14.7 1.6 0.80 to 3.61 0.078
Onset (>18/≤18 years) 21:1194/34:1356 17.5/25 0.7 0.38 to 1.24 0.101
Hypertension (yes/no) 8:481/47:2069 16.6/22.7 0.7 0.29 to 1.56 0.213
Dyslipidemia (yes/no) 12:546/43:2004 21.9/21.4 1.1 0.49 to 1.97 0.459
Diabetic nephropathy (yes/no) 4:168/51:2382 23.8/21.4 1.1 0.29 to 3.02 0.394
Smoking habit (yes/no) 13:585/42:1965 22.2/21.3 1.1 0.51 to 1.97 0.441
DR, diabetic retinopathy; HbA1c, glycated hemoglobin.
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analyzed as a function of onset of DM. That is, patients 
who had an onset at >18 years of age and from a lower 
socioeconomic area present with an almost tripled level 
of risk of developing DR than those who developed DM 
in infancy or adolescence and from areas of less depri-
vation. However, in the rest of the combinations of age 
of onset and socioeconomic levels, we did not find any 
significant associations.
The finding of an association between low socioeco-
nomic level and the development of DR concurs with 
other studies published to date by various research 
groups, and in different geographic areas. The relation-
ship between education level and the development of 
DR was described by Klein et al26 who observed a higher 
risk of DR in women with a low education level, coex-
isting with early onset of DM. Two subsequent studies 
conducted in the UK also described associations between 
low education level and a high prevalence of DR.27 28 Our 
results are similar to those obtained in a study conducted 
in China in which a higher education level and higher 
net income were associated with reduced DR incidence.29
A study conducted in France analyzed the correlation 
between the index of individual deprivation (‘EPICES 
scores’) and glycemic control with the associated compli-
cations of DM. The authors found that the prevalence of 
DR was higher in patients with lower socioeconomic level 
(mean 3.66; 95% CI 1.39 to 9.64; p=0.009) and that this 
association persisted following adjustment for glycemic 
control.30 Several studies in the UK correlated low socio-
economic level with DR. One of these studies observed an 
association between low socioeconomic level (measured 
as the ‘Index of Multiple Deprivation’) and the presence 
of DR susceptible to treatment.15 Another study showed 
similar outcome for T1DM17 but no significant associa-
tion for T2DM, and another showed the presence of this 
association with proliferative DR.16 Such associations 
detected were shown to be independent of the duration 
of the disease, the values of HbA1c, the concentrations of 
lipoproteins, and presence of hypertension.
Only in the study published by Klein et al26 was there 
a difference observed between the onset of DM and the 
influence of socioeconomic factors in the development 
of DR. In this case, a greater risk was observed in patients 
with onset <18 years of age, which is contrary to that 
observed in our study in which the risk is increased in 
those patients who had onset >18 years of age.
Several hypotheses have been proposed to explain the 
relationship between socioeconomic deprivation and the 
increased risk of DR. Different factors have been invoked 
such as poor access to healthcare services because of the 
existence of economic barriers, or even factors associated 
with a clear deterioration of the quality of life. One postu-
lation is that environmental factors in deprived areas 
can unlink immune responses in individuals genetically 
predisposed to developing T1DM, which can accelerate 
the appearance, or progression, of complications of the 
disease.31 Another postulation is that of a lower participa-
tion in primary prevention screening programs in more 
deprived areas15 which could increase the risk of more 
advanced forms of DR being identified in later diagnosis. 
Further, it is important to consider the impact of the 
complications of DM on the education level and working 
practices, especially when DR complications are involved. 
In our case, the high healthcare cover in the population 
(especially pediatric services) could explain the lower 
influence of socioeconomic status of the patients with 
early onset. The education level could be another factor 
explaining the interaction between onset of DM and the 
socioeconomic level since there would not be as much 
influence in the pediatric population, as there may be 
in adulthood, that is, in our universal healthcare system, 
the neonates are followed up with more attention than 
subsequent adolescence or adulthood when the uptake 
of healthcare facilities is more a function of the individ-
ual’s choice.
We observed an incidence rate of 21.6 cases/1000 
patient- years and a cumulative incidence of various 
grades of DR of 36.6%. To the best of our knowledge, 
there has been only one study of incidence density of 
DR in cohorts of patients with T1DM. The study had 
observed 97.7 cases/1000 person- years.32 This is a finding 
that is much higher than ours. In the UK, disparate 
cumulative incidences between 47% and 97% have been 
published by Wisconsin Epidemiologic Study of Diabetic 
Table 4 Cox proportional hazards model for the development of DR in patients with T1DM
Variable Category HR 95% CI P value
HbA1c mean (%) 1.6 1.19 to 2.10 0.002
Age of onset of DM
Deprivation: census section
<18 years/no deprivation Reference – –
<18 years/medium deprivation 1 0.44 to 2.49 0.986
<18 years/high deprivation 0.5 0.20 to 1.46 0.227
≥18 years/no deprivation 0.7 0.24 to 1.88 0.454
≥18 years/medium deprivation 1.2 0.51 to 2.96 0.640
≥18 years/high deprivation 2.9 1.08 to 8.00 0.033
Sex Male Reference – –
Female 0.9 0.48 to 1.60 0.694
DM, diabetes mellitus; DR, diabetic retinopathy; HbA1c, glycated hemoglobin; T1DM, type 1 diabetes mellitus.
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Retinopathy.33–36 Other studies, as well, have observed 
incidence levels much lower than ours, of between 20% 
and 35%.37–39 To compare these studies we must take into 
account two fundamental factors jointly: the duration of 
the T1DM at the start of the follow- up, and the grade 
of glycemic control. DR is time dependent and several 
studies show that with a sufficiently long follow- up time, 
most patients with T1DM will develop DR, so that the 
time of evolution of DM can be considered the main risk 
factor for DR.36 40
The other fundamental factor influencing the inci-
dence of DR is glycemic control. Patients with poor meta-
bolic control present with higher incidences33 34 41 than 
those with better control.37 42 In our cohort of patients, 
those who developed DR presented with a higher baseline 
HbA1c than those who did not develop DR, and in multi-
variable analyses, the mean HbA1c levels were shown to 
be an independent risk factor for the development of 
DR; with no significant differences noted with respect to 
sex. These data are concordant with those published in 
other studies that showed HR between 1.237and 4.2.43
We did not observe any significant association in the 
development of DR with respect to the other risk factors 
such as hypertension, dyslipidemia, diabetic nephropathy, 
and the smoking habit. In similar studies, an association 
was observed between hypertension and DR especially 
between diastolic pressure and proliferative DR.35 41 With 
respect to dyslipidemia, Romero- Aroca et al observed 
significant association between the ApoB/ApoA1 ratio 
and the LDL to high- density lipoprotein cholesterol ratio 
and DR.40 42 Similarly, significant associations between 
DR and diabetic nephropathy6 and smoking44 have been 
communicated. This disparity in the findings could be 
due to several causes including the heterogeneity of the 
study sample, and the duration of DM follow- up. The 
population studied was characterized by its youth, as well 
as the absence, almost, of comorbidities.
Of importance is our novel finding that there is a signifi-
cant relationship between economic deprivation and inci-
dence of DR in patients with T1DM. Our results suggest 
that socioeconomic levels need to be taken into account 
as a risk factor when designing screening strategies for 
DR. Also, this factor affects the adherence to outpatient 
clinic consultations and screening programs; especially 
in those individuals who were diagnosed with T1DM after 
18 years of age. As such, it is essential to develop and 
promote new social policies centered on this risk group 
with the objective of reducing the consequences of social 
inequalities in groups with low socioeconomic levels. 
Despite there being universal healthcare provision in our 
environment with free access to healthcare, the socioeco-
nomic level still appears to play a significant role.
As limitations of the study, we need to highlight that 
the results obtained refer to a specific hospital catch-
ment area and, as such, is not translatable to other situ-
ations with different characteristics. Also, comparisons 
with other studies need to be undertaken with caution 
because of the different measures of socioeconomic 
status. Moreover, our study requires further specific 
details on variables associated with service utilization, for 
example, the number of visits or adherence to treatment 
which may associate with socioeconomic status and, as 
such, could shed more light on the links between depri-
vation and DR.
Hence, we consider it necessary to apply this study 
model to other studies under different socioeconomic 
conditions in order to confirm the impact of the socio-
economic deprivation, together with other risk factors of 
known importance, in the development of DR in patients 
with T1DM.
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